San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

Birth of a Blockbuster?

PHARMA: Acadia Prepares To Launch Drug to Treat Parkinson’s Psychosis

Acadia Pharmaceuticals Inc. has earned the greenlight from regulators to sell a valuable antipsychotic drug. The medication, potentially worth billions, quells the hallucinations and delusions experienced by Parkinson’s disease patients. And it’s the first of its kind.

Stocks Down For 3 Life Science Firms After Earnings Reports

Three public life science firms in San Diego are suffering stock slips after reporting first quarter earnings Wednesday. Two of the firms missed analyst expectations and one exceeded Wall Street’s forecast, but barely.

Ionis Sells Drug Rights to Kynamro in Deal Potentially Worth More Than $95M

In a deal worth up to $95 million-plus, San Diego drugmaker Ionis Pharmaceuticals sold global rights to develop and commercialize its marketed drug Kynamro to Chicago-based Kastle Therapeutics.

Illumina's Revenue Fails to Match Forecasts for Q1

San Diego’s Illumina Inc. reported quarterly earnings May 3, falling short of analyst expectations and further slipping the company’s stock.

Dexcom Inc. Acquires European Distribution Partner Nintamed

Dexcom Inc., one of San Diego’s biggest public medical technology firms, announced May 2 that it will acquire Nintamed, a distribution partner with presence in Germany, Switzerland and Austria.

Philanthropists Donate $11.8 million to UC San Diego to Launch Geriatric Emergency Care Unit

Local philanthropists Gary and Mary West have provided $11.8 million to the University of California, San Diego to create a senior emergency care unit at the future Jacobs Medical Center.

MedOptions To Acquire San Diego-Based Vericare

MedOptions announced a definitive agreement to acquire San Diego’s Vericare, a behavioral health clinical care provider.

Startup MyDx Makes Revenue Gains

San Diego’s MyDx Inc., a company that makes a handheld chemical analyzer for consumers, announced a jump in quarterly revenue as the startup gains traction.

Biocept Inc. Prices Common Stock Offering

San Diego-based Biocept Inc. is hoping to raise $5 million in an offering of its common stock, the company announced April 29.

Ignyta Inc. Looking to Raise $50 Million in Stock Offering

San Diego’s Ignyta Inc., a drugmaker developing cancer therapeutics, is hoping to raise $50 million in an offering of its common stock, the company announced Wednesday.

Tease photo

After Weight-Loss, Arena Has Options

PHARMA: New Painkiller And Other Drugs Being Tested

It’s been a rocky year for Arena Pharmaceuticals Inc., but things are looking up with its latest experimental drug: a painkiller that mimics cannabis without the head high.

Dexcom Reports 60 Percent Jump in Q1 Revenue

Dexcom Inc., one of San Diego’s biggest public medical technology firms, reported a 60 percent jump in revenue for the first quarter of this year.

ResMed's Q1 Net Income Drops to $88.5 Million

San Diego medical device company ResMed Inc. reported a drop in net income for the first quarter of 2016.

NuVasive's Q1 Earnings Report Better Than Expected

San Diego medical device maker NuVasive Inc. exceeded Wall Street expectations Tuesday when it reported a boost in revenue and an improved bottom line.

Ronald Rittenmeyer Named CEO at Millennium Health

Millennium Health, a drug-testing firm in San Diego, announced that Chairman of the Board Ronald Rittenmeyer is taking over as CEO.